Nursing care
Naloxone: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Naloxone reverses opioid overdose by displacing opioids from mu receptors within about two minutes, but its effect lasts only thirty to ninety minutes. Most opioids outlast that window, so the patient can slip back into respiratory depression after apparent recovery. Continuous monitoring after the first dose is not optional.
Why this drug and not another
Naloxone is a pure opioid antagonist. It has no analgesic effect, no abuse potential, and does nothing if opioids are not on board. That specificity is why it is the first drug reached for in suspected opioid toxicity rather than a general respiratory stimulant.
The mechanism is competitive displacement at the mu receptor. Give it and within roughly two minutes the patient's respiratory rate should climb and pupils should stop being pinpoint. But naloxone's own half-life is short, thirty to ninety minutes, while morphine, oxycodone, and especially methadone or fentanyl patches persist far longer. The drug that caused the overdose is often still working long after the antidote has cleared.
Administration and timing
IV is the fastest route and the one used in acute respiratory depression, typically 0.4 to 2 mg, repeated every two to three minutes if response is inadequate. IM, subcutaneous, and intranasal routes exist for community and take-home use and have a slightly slower onset but the same short duration.
Titrate to respiration, not to full alertness. The goal is a respiratory rate that supports oxygenation, not a wide-awake patient. Pushing naloxone until someone is fully alert in an opioid-dependent patient invites abrupt, severe withdrawal and a combative patient who then needs restraint and further sedation to manage — the opposite of what you were trying to achieve.
Monitoring parameters
Respiratory rate, depth, and oxygen saturation come first, checked at minimum every fifteen minutes for the first two hours after reversal. Because naloxone wears off faster than most opioids, the real monitoring burden is not the immediate response, it is the hours afterward.
Track level of consciousness and pupil size alongside vitals. A patient who was reversed and then becomes drowsy again with pinpoint pupils and a falling respiratory rate is re-narcotizing, and that patient needs another dose or an infusion, not reassurance. Continuous pulse oximetry and cardiac monitoring are standard in the post-reversal period, and the patient should not be discharged or left unsupervised until that window has passed.
Adverse effects to report
Precipitated opioid withdrawal is the adverse effect that defines naloxone use in dependent patients: sweating, tachycardia, hypertension, nausea, vomiting, agitation, and generalised pain, appearing within minutes of administration. It is uncomfortable and frightening for the patient but not itself the emergency it looks like.
The true emergency is re-sedation after the naloxone wears off, which can present hours later as recurrent respiratory depression, hypoxia, and unresponsiveness. Pulmonary oedema has been reported after naloxone reversal, so new dyspnoea, crackles, or frothy sputum after apparent recovery should be reported immediately, not attributed to anxiety.
Contraindications and cautions
There is no absolute contraindication to naloxone in a life-threatening opioid overdose. The caution is about dose and rate, not whether to give it at all: in a patient physically dependent on opioids, full-dose rapid reversal can trigger severe withdrawal, hypertensive crisis, or arrhythmia, so smaller incremental doses titrated to respiratory effort are preferred where the clinical picture allows time for that.
Use caution in patients with known cardiac disease, since the surge of catecholamines during precipitated withdrawal can provoke arrhythmia or myocardial ischaemia. Naloxone will not reverse respiratory depression from non-opioid causes such as benzodiazepines alone, so if there is no response after two or three doses, reassess the differential rather than continuing to redose.
Teaching points the exam tests
The single most tested fact is the mismatch in duration: naloxone lasts thirty to ninety minutes, most opioids last considerably longer, so a reversed patient must be monitored for renarcotization rather than discharged once they wake up. Expect an NCLEX item where the correct answer is continued monitoring or a repeat dose, not congratulating yourself on a successful reversal.
Also expect questions on titration to respiratory rate rather than to consciousness, on recognising precipitated withdrawal as an expected finding rather than a reason to withhold further doses, and on naloxone's lack of effect on non-opioid sedatives. For families and patients receiving take-home naloxone kits, teach that a second dose may be needed if there is no response in two to three minutes, and that emergency services should still be called even after a successful reversal, because the effect will not outlast the opioid.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
How long does naloxone last compared to opioids?
Naloxone's effect lasts roughly thirty to ninety minutes. Most opioids, and especially long-acting ones like methadone or fentanyl patches, remain active well beyond that, which is why patients need monitoring after reversal rather than discharge.
What is the target when titrating naloxone?
Titrate to an adequate respiratory rate and oxygenation, not to full alertness. Overshooting into complete arousal in an opioid-dependent patient causes abrupt, severe withdrawal.
Is precipitated withdrawal dangerous?
It is distressing and can raise heart rate and blood pressure sharply, but it is not usually life-threatening on its own. Monitor cardiac patients closely during it, and treat symptoms supportively rather than withholding further naloxone if respiratory depression persists.
Does naloxone work on benzodiazepine overdose?
No. Naloxone is opioid-specific and has no effect on benzodiazepines, alcohol, or other CNS depressants. Absent response after two or three doses should prompt reassessment of the cause of respiratory depression.
Can a patient go home after one dose of naloxone reverses them?
Not safely, given naloxone's short duration relative to most opioids. Standard practice is observation for at least one to two hours after the last dose, longer for long-acting opioids, before considering discharge.
More on pharmacology
Guides on this